Philadelphia, PA, United States of America

Daniel Bauer

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Pennsylvania. Active years: 2015.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Daniel Bauer

Introduction

Daniel Bauer is an accomplished inventor based in Philadelphia, PA. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on utilizing specific inhibitors to combat cancer effectively.

Latest Patents

Daniel Bauer holds a patent for "Compositions and methods for treating cancer." This patent discloses methods of treating individuals identified as having cancer using ATP citrate lyase inhibitors and/or tricarboxylate transporter inhibitors. The methods include inducing apoptosis in cancer cells and treating individuals with a high rate of aerobic glycolysis. Additionally, the patent outlines methods for identifying compounds with anticancer activity.

Career Highlights

Bauer is affiliated with the University of Pennsylvania, where he conducts his research and develops his innovative treatments. His work has the potential to change the landscape of cancer therapy, providing new avenues for treatment.

Collaborations

Daniel Bauer has collaborated with notable colleagues, including Craig B. Thompson and Georgia Hatzivassiliou. These partnerships enhance the research and development of effective cancer treatments.

Conclusion

Daniel Bauer's contributions to cancer treatment through his innovative methods and patents highlight the importance of research in combating this disease. His work at the University of Pennsylvania continues to pave the way for advancements in cancer therapy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…